skip to Main Content
HISTORY
2024
Jul
  • Established CPO Headquarter, reorganized CTM Division under the HQ
  • Hosted the ‘Corporate Presentation for Institutional Investors and Analysts’
Jun
  • MOU with Microsoft Korea and Trial Informatics to ‘Develop IT solution for Clinical Trials using Microsoft Azure AI’
  • Hosted the ‘2024 The 9th C&R Research Symposium’
  • MOU with Chonnam National University Hwasun Hospital to ‘Strengthen Data Utilization in Clinical Research’
Apr
  • MOU with GC Cell to ‘Strengthen Global Clinical Competitiveness’
Jan
  • MOU with Sungkyunkwan University College of Pharmacy for ‘Clinical Trial Platform Development’
2023
Dec
  • Received the ‘Innovative CRO’ Certification from KoNECT
Nov
  • Establishment of C & R Research US Inc
Oct
  • Establishment of C&R Healthcare Global (Thailand) Co., Ltd.
Sep
  • Signed MOU with Gwangju Alzheimer’s & related Dementia Cohort Research Center (GARD), KOLAB, and GCCL : Joint academic research and technical partnerships related to dementia and geriatric diseases
  • Hosted the ‘2023 C&R imagineer: Healthcare Data Industry, the Present & the Future’
Jul
  • Selected as a government project related to clinical trial data standardization
  • Signed MOU with Kyung Hee University Hospital at Gangdong : Advancement of medical data utilization technology and strengthening clinical trial competitiveness
May
  • Signed MOU with SAS for fostering clinical professional SAS Programmers
Mar
  • Established ABCbioscience
  • Signed MOU with Aptamer Sciences, Inc. for liver cancer treatment clinical research
  • COO Headquarters reorganization, Established ‘CO Division’
2022
Nov
  • Established Future Strategy T/F for growth Global CRO
Oct
  • Signed MOU with Mediplexus for activating real world evidence research
Sep
  • Singed MOU with Wonkwang Universty Hospital for maximizing clinical research and research performance
Aug
  • Win an award for contributing to creating an atmosphere for creating quality jobs
June
  • Hosted the 8th C&R Symposium – Global Clinical Trial Strategy
Mar
  • Singed MOU with Seoul National University for execution Multi-Regional Clinical Trial
Jan
  • Singed MOU with WRRS, U.S. FDA regulatory consulting company
2021
Dec
  • Listed on KOSDAQ market
  • Established ‘Global RA Team’ (for FDA approvals)
Aug
  • Achieved ISO9001 certified Quality Management System
June
  • Hosted the 7th C&R Symposium – Clinical Trial environment change and IT System/Platform application
May
  • Released “CsafeR“, electronic report on adverse drug reactions
Apr
  • Implemented domestic multi-ethnic clinical trials
2020
Oct
  • Highest Score in 2020 KoNECT CRO Certification Evaluation
Jul
  • Singed MOU with InhandPlus for Joint development of AI-based medication management solution
Apr
  • C&R Healthcare Global signed MOU with a Singapore distribution company, Hebeloft Pte Ltd, to support overseas market development for Korean beauty and health products
  • Signed MOU with Asan Image Metrics for Imaging Lab service of clinical trials
  • the Top CRO of APAC in 2020 by pharma tech outlook
Mar
  • Singed MOU with Ajou university hospital for Open Laboratory
  • Singed MOU with Woojungbio for Global New Drugs Joint Research and Development
Feb
  • Singed MOU with Dongguk University BMC (BioMedical Commercialization)
Jan
  • GCCL, Designation of a clinical trial sample analysis institution
2019
Nov
  • Singed MOU with Gangnam Severance Hospital
Oct
  • Singed MOU with Busan Paik Hospital for Open Laboratory
  • Signed a Master Collaboration Agreement with the US CRO(Eastern US based, European corporate operating)
Sep
  • Participated in 2019 KoNECT International Conference
Aug
  • Established joint venture, GCCL
  • Opened Korean cosmetics promotion and sales floor in Singapore
    (Selected as a government support business operator)
Jul
  • Established ‘Drug development Consulting (DC) Team’
  • Invest in Bio-venture, ApitBio
  • Selecting a resident company and supporting service for new conceptual treatment technology development platform for Korea Institute of Radiological & Medical Sciences using RI
June
  • Hosted the 6th C&R Symposium – Trend Updates in Clinical Trials
May
  • Chairman Moon-tae Yoon awarded a man of Clinical Trial Merit at the World Clinical Trial Day Celebrations
Apr
  • Chief Medical Officer, Byung-jin Ahn (MD, PhD) awarded a man of Health Industry Merit at the 6th Bio Korea Commemorative Event
Mar
  • Established ‘Global Team’ dedicated to overseas clinical projects
Feb
  • Signed MOU with Legochembio
Jan
  • Established ‘Clinical Trials Management (CTM) Team’
2018
Dec
  • C&R Healthcare Global signed MOU with ZIG MedTech Asia
Nov
  • Signed MOU with GNP Bioscience for gene therapy
  • Signed MOU with VaxcellBio for anticancer immunotherapy
Sep
  • C&R Lewei Signed a Strategic Partnership Agreement with Beijing Baiao Pharmat
Aug
  • Chairman Moon-tae Yoon listed in ‘Marquis Who’s Who‘
June
  • Participated in 2019 BIO International Convention (2019 BIO USA)
  • Hosted the 5th C&R Symposium – Trend Updates in Clinical Trials
May
  • Opened Korean Cosmetic Pop-up Booth in Singapore
    (Selected as a government support business operator)
Apr
  • C&R ACADEMY implemented pilot training in Clinical Research Malaysia
  • Singed MOU with Newflight
2017
Nov
  • C&R Healthcare Global signed MOU with Dongguk Univ. Medical R&D center for fusion technology and commercialization
  • Hosted 1st Korean – Chinese clinical symposium – Trend Updates in Clinical Trials
Oct
  • C&R Healthcare Global signed MOU with US W Medical Strategy Group
  • Launched LeadTrial CTMS
Sep
  • C&R Healthcare Global signed MOU with Sinagpore Golden Equator
  • Established C&R-LEWEI JV in China
June
  • Hosted the 4th C&R Symposium – Trend Updates in Clinical Trials
  • Participated in DIA 2017 KoNECT delegation
Apr
  • Established C&R Healthcare Global Pte. Ltd. in Singapore
Jan
  • Signed MOU with Clinical Research Malaysia (CRM) in Malaysia
  • Opened Singapore Incubating Center
2016
Nov
  • Participated in the recruitment fair of Seoul Biomedical Conference
  • Exhibited a booth in an international conference organized by KoNECT
  • Co-hosted a symposium with SCI-C
Oct
  • Established Q-fitter Inc. for pharmacometric consulting, a subsidiary of C&R Research
Aug
  • Signed MOU with KoNECT forattracting overseas clinical trials into Korea
  • C&R ACADEMY achieved ISO9001 certified Quality Management System(ex post facto screening)
Jun
  • Hosted the 3rd C&R Symposium – Trend Updates in Clinical Trials
May
  • Launched LeadTrial, a web-based integrated platform for conduct and management of clinical trials
  • Signed MOU with Severances-Catholic-Inha University Hospitals Consortium (SCI-C)
  • Signed MOU with Apollo Bio in China
Apr
  • C&R Academy was designated by Ministry of Food and Drug Safety (MFDS) as an official education center for clinical trials, with expansion of its training center
  • Signed MOU with Biomedical Research Institute, Inha University Hospital for joint research in clinical trials
Mar
  • Signed MOU with Pharmacometrics Institute for Practical Education and Training (PIPET) at Catholic University forpharmacometric consulting service
2015
Dec
  • Adopted MedidataClinical Cloud
Nov
  • Participated in an international conference organized by Korea National Enterprise for Clinical Trials (KoNECT)
Oct
  • Participated in Korea-ChinaMedical Device Seminar
  • Signed MOU with Tego Sciencefor strategic partnership
  • Signed MOU with CTC of Chonnam National University Hospital
Aug
  • Signed MOU with CTC of Seoul National University Bundang Hospital for mutual collaboration
Jul
  • Hosted the 2nd C&R Symposium – Trend Updates in Clinical Trials
June
  • Completed the head office building of C&R Research in Gangnam
May
  • Lectured by Medical Device Information & Technology Assistance Center (MDITAC); “Medical Device Clinical Trials” (intensified training)
Apr
  • Lectured by Korea Medical Devices Industry Association (KMDIA); “National Human Resource Development Consortium Project (CHAMP)”
Feb
  • Head of C&R Academy awarded by a Minister of Food and Drug Safety in recognition for “Development of Biopharmaceutical Industry”
2014
Dec
  • Adopted document centralization and security reinforcement policy (ClouDoc)
Nov
  • Lectured on Chinese Course on Drug Development and Regulatory Sciences (CCDRS) in Beijing University
Oct
  • Lectured on “New Drug Development and Clinical Research Associates” in College of Pharmacy, Gachon University
June
  • Hosted the 1st C&R Symposium – Trend Updates in Clinical Trials
  • Attended 2014 KASBP Spring Symposium
May
  • Exhibited a booth in the 8th DIA Annual Conference in Japan for Asian New Drug Development (A-PACT)
  • Participated in 2014 BioKorea Business Partnering
  • Moved to Seongdong Office
Mar
  • Exhibited a booth in 2014 BioPharma ASIA Convention, Singapore (A-PACT)
Feb
  • Signed MOU with CTC of Chungnam National University and Meditip for mutual collaboration
2013
Dec
  • Signed a Service Partnership Agreement with Medidata
Nov
  • Expanded Busan Office
  • Participated in the 2nd A*STAR – KHIDI Workshop on 2013 Bio/Meditech Innovation
  • Exhibited a booth in the 10th Annual Meeting DIA Japan 2013 (A-PACT)
Sep
  • Exhibited a KCROA booth in 2013 BIO Korea
  • Exhibited a booth in 2013 DIA Korea
May
  • Signed MOU with Professional Science Master (PSM) of Chungbuk National University as industry-academia cooperation
  • Exhibited a booth in the 2nd Global Clinical Trials Outsourcing Summit (Seoul)
Apr
  • Exhibited a booth in the 7th Annual Conference in Japan for Asian New Drug Development (A-PACT)
2012
Nov
  • Designated as QA service vendor for global lead clinical trial center (Seoul National University Hospital Consortium)
Oct
  • Exhibited a KCROA booth in 2012 Bio Korea
Aug
  • Launched T-doc (EDC System)
  • Signed MOU with SCAS-BTT Bioanalysis, a Korea-Japan JV biolaboratory for mutual collaboration
Jul
  • Launched Clinical Quality Management System Service
May
  • Established the Alliance for Pac-Asia Clinical Trials (A-PACT), an multinational CRO organization representing Korea, China, Japan and Taiwan
  • Signed MOU with AC Medical in Japan for mutual collaboration in clinical trials
  • Exhibited a booth in DIA China
Feb
  • Created a Late Phase Study (LPS) Department
2011
Nov
  • Selected as preferred CRO by National Onco Venture
Sep
  • Signed MOU with Korea Institute of Technology (KIT)
  • Established C&R Research R&D Center, certified by Korea Industry Technology Association
  • C&R Academy achieved ISO 9001:2008 certification (Design, Development, Conduct and Service of Education & Training for Clinical Research Professionals)
Aug
  • Hosted an information session for entering into Chinese pharmaceutical market
Jul
  • Exhibited a booth in the 9th Inter Biz Bio Partnering & Investment Forum 2011
  • Exhibited a booth in New Drugs China 2011, Nanjing, China
Jun
  • Exhibited a booth in the 47th Annual Meeting 2011, DIA, USA
May
  • Launched the C&R Optimal SAE Management Operating System (COSMOS)
Apr
  • Exhibited a booth in 2011 AHC-DIA-IFPMA Asia Regulatory Conference
March
  • Established C&R Research China
2010
Nov
  • Exhibited a booth in 2010 DIA Korea
Oct
  • Exhibited a booth in 2010 DIA Japan 2010
  • Established JOVIA Ltd. (Joint Vision Asia Ltd.), a clinical consulting and outsourcing organization in Asia-Pacific region
June
  • Selected by Korea Biotechnology Association as a leading CRO in the government’s new initiative to conduct clinical trials for biosimilars
  • Exhibited a booth in 2010 DIA USA
May
  • Established C&R Academy, a C&R internal and external training center
  • Selected by Pan Asian Clinical Research Association (PACRA) as the “Korean Representative Regional Director Company”
Jan
  • Exhibited a booth in 2010 DIA Japan 2010
2009
Nov
  • Signed MOU with CTC of Korea University Hospital
Oct
  • Signed MOU with CTC of Busan Inje University Paik Hospital
Sep
  • Exhibited a booth with GC Laboratories in 2009 Bio Korea
Apr
  • Selected by Novartis Korea as preferred vender in clinical trial services
Feb
  • Opened Gangnam Office
Jan
  • Signed MOU with GC Laboratories
2008
Oct
  • Selected by GSK Korea as preferred vender in clinical trial services
Sep
  • Signed a Master Service Agreement with Kendle (clinical trial services)
Jun
  • Frost & Sullivan Award “South Korea Clinical Research Organization of the year” for the first time in Korea
2007
Sep
  • Exhibited a booth in 2007 Bio Korea
2006
Nov
  • Started QA/Audit services
Oct
  • Signed a memorandum of understanding (MOU) with Busan Inje University Paik Hospital for mutual collaboration
  • Opened Busan Office
Apr
  • Moved a Head Office of C&R Research
2002
May
  • Started Data Management / Biostatistics services
2001
Mar
  • Started Regulatory Affairs services
2000
Mar
  • Changed the company name to C&R Research Inc.
1997
Jul
  • Started CRO services (clinical trial monitoring, etc.)
  • Established C&R Consulting
Back To Top